Search
| Leader | 00000nz a2200037n 45 0 | ||
|---|---|---|---|
| 001 | WKP|Q89366831 (VIAF cluster) (Authority/Source Record) | ||
| 003 | WKP | ||
| 005 | 20241221010743.0 | ||
| 008 | 241221nneanz||abbn n and d | ||
| 035 | ‡a (WKP)Q89366831 | ||
| 024 | ‡a 0000-0002-0006-7614 ‡2 orcid | ||
| 035 | ‡a (OCoLC)Q89366831 | ||
| 100 | 0 | ‡a Mario O Salazar ‡c researcher ‡9 en | |
| 400 | 0 | ‡a Mario O Salazar ‡c onderzoeker ‡9 nl | |
| 670 | ‡a Author's A New Fluorinated Tyrosinase Inhibitor from a Chemically Engineered Essential Oil | ||
| 670 | ‡a Author's Arylsulfonyl histamine derivatives as powerful and selective α-glucosidase inhibitors | ||
| 670 | ‡a Author's Metabolic Footprinting of a Clear Cell Renal Cell Carcinoma in Vitro Model for Human Kidney Cancer Detection | ||
| 670 | ‡a Author's Modified β-cyclodextrin inclusion complex to improve the physicochemical properties of albendazole. complete in vitro evaluation and characterization | ||
| 670 | ‡a Author's New α-glucosidase inhibitors from a chemically engineered essential oil of Origanum vulgare L. | ||
| 670 | ‡a Author's Thin Layer Chromatography-Autography-High Resolution Mass Spectrometry Analysis: Accelerating the Identification of Acetylcholinesterase Inhibitors | ||
| 909 | ‡a (orcid) 0000000200067614 ‡9 1 | ||
| 919 | ‡a newαglucosidaseinhibitorsfromachemicallyengineeredessentialoiloforiganumvulgare50 ‡A New α-glucosidase inhibitors from a chemically engineered essential oil of Origanum vulgare L. ‡9 1 | ||
| 919 | ‡a thinlayerchromatographyautographyhighresolutionmassspectrometryanalysisacceleratingtheidentificationofacetylcholinesteraseinhibitors ‡A Thin Layer Chromatography-Autography-High Resolution Mass Spectrometry Analysis: Accelerating the Identification of Acetylcholinesterase Inhibitors ‡9 1 | ||
| 919 | ‡a newfluorinatedtyrosinaseinhibitorfromachemicallyengineeredessentialoil ‡A A New Fluorinated Tyrosinase Inhibitor from a Chemically Engineered Essential Oil ‡9 1 | ||
| 919 | ‡a arylsulfonylhistaminederivativesaspowerfulandselectiveαglucosidaseinhibitors ‡A Arylsulfonyl histamine derivatives as powerful and selective α-glucosidase inhibitors ‡9 1 | ||
| 919 | ‡a metabolicfootprintingofaclearcellrenalcellcarcinomainvitromodelforhumankidneycancerdetection ‡A Metabolic Footprinting of a Clear Cell Renal Cell Carcinoma in Vitro Model for Human Kidney Cancer Detection ‡9 1 | ||
| 919 | ‡a modifiedβcyclodextrininclusioncomplextoimprovethephysicochemicalpropertiesofalbendazolecompleteinvitroevaluationandcharacterization ‡A Modified β-cyclodextrin inclusion complex to improve the physicochemical properties of albendazole. complete in vitro evaluation and characterization ‡9 1 | ||
| 996 | ‡2 BNF|12554657 | ||
| 996 | ‡2 DNB|171198913 | ||
| 996 | ‡2 NTA|398434646 | ||
| 996 | ‡2 LC|no2022048849 | ||
| 996 | ‡2 DNB|1046969188 | ||
| 996 | ‡2 LC|no2008001794 | ||
| 996 | ‡2 ISNI|0000000059387757 | ||
| 996 | ‡2 BNF|12963396 | ||
| 996 | ‡2 J9U|987007355313005171 | ||
| 996 | ‡2 ISNI|0000000080534395 | ||
| 996 | ‡2 LC|n 88209103 | ||
| 996 | ‡2 BNE|XX1200396 | ||
| 996 | ‡2 LC|no 00030502 | ||
| 996 | ‡2 RERO|A003779872 | ||
| 996 | ‡2 LC|no2004103073 | ||
| 996 | ‡2 DNB|1271068591 | ||
| 996 | ‡2 ISNI|0000000060987661 | ||
| 996 | ‡2 ISNI|0000000390761884 | ||
| 996 | ‡2 ISNI|0000000021077550 | ||
| 996 | ‡2 DE633|pe50050262 | ||
| 996 | ‡2 ISNI|0000000356524754 | ||
| 996 | ‡2 LC|no2013098193 | ||
| 996 | ‡2 BNE|XX1426100 | ||
| 996 | ‡2 ISNI|000000011753279X | ||
| 996 | ‡2 J9U|987007327101505171 | ||
| 996 | ‡2 RERO|A005466902 | ||
| 996 | ‡2 NTA|252337808 | ||
| 996 | ‡2 CAOONL|ncf11467441 | ||
| 996 | ‡2 ISNI|0000000042418609 | ||
| 996 | ‡2 RERO|A006021344 | ||
| 996 | ‡2 DNB|1057453161 | ||
| 996 | ‡2 LC|n 80000524 | ||
| 996 | ‡2 SUDOC|243250444 | ||
| 996 | ‡2 ISNI|0000000119750758 | ||
| 996 | ‡2 BNE|XX1564088 | ||
| 996 | ‡2 RERO|A008706695 | ||
| 996 | ‡2 BNCHL|10000000000000000079017 | ||
| 996 | ‡2 BNCHL|10000000000000000011506 | ||
| 996 | ‡2 DNB|1056388269 | ||
| 996 | ‡2 BIBSYS|90205993 | ||
| 996 | ‡2 NUKAT|n 2014081429 | ||
| 996 | ‡2 LC|n 86020349 | ||
| 996 | ‡2 BNCHL|10000000000000000244058 | ||
| 996 | ‡2 NUKAT|n 2010154131 | ||
| 996 | ‡2 ISNI|0000000037142353 | ||
| 996 | ‡2 LC|no2010038672 | ||
| 996 | ‡2 NSK|000728023 | ||
| 996 | ‡2 BNE|XX4618439 | ||
| 996 | ‡2 SZ|1089612354 | ||
| 996 | ‡2 ISNI|000000004486627X | ||
| 996 | ‡2 LC|n 94094412 | ||
| 996 | ‡2 LC|n 2011184392 | ||
| 996 | ‡2 DNB|1057272620 | ||
| 996 | ‡2 BNE|XX1428963 | ||
| 996 | ‡2 LC|nb 98040653 | ||
| 996 | ‡2 BNC|981058511266506706 | ||
| 996 | ‡2 DNB|1157359566 | ||
| 996 | ‡2 SELIBR|344563 | ||
| 996 | ‡2 SUDOC|080569315 | ||
| 996 | ‡2 BNCHL|10000000000000000170961 | ||
| 996 | ‡2 LC|no2019153591 | ||
| 996 | ‡2 ISNI|0000000047792974 | ||
| 996 | ‡2 DNB|1089612354 | ||
| 997 | ‡a 0 0 lived 0 0 ‡9 1 |
